Forbes March 8, 2021
The genetic medicine industry is growing rapidly, increasing the demand for DNA at an exponential rate. This need is being driven even higher as more companies focus on manufacturing COVID-19 vaccines and other types of mRNA products.
Synthetic biology has the potential to revolutionize this emerging industry and solve the DNA supply problem for genetic medicine. Recent advances in pure, synthetic DNA from Touchlight in the United Kingdom could be the type of disruptive technology that manufacturers need to scale.
Genetic Medicine Is the Future
Genetic medicine focuses on using DNA and RNA to deliver therapeutics. Vaccines and other products that rely on mRNA are a growing sector in the synthetic biology industry. These novel therapeutics create...
Today's Sponsors
Today's Sponsor